Bellicum Pharmaceuticals, Inc logo

Bellicum Pharmaceuticals, Inc Share Price Today (NASDAQ: BLCM)

Bellicum Pharmaceuticals, Inc share price is $0 & ₹0.00 as on 3 Mar 2024 IST

▲

-0.07

(-100%)

Market is closed - opens 7 PM, 20 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 4 Mar 2024

View live Bellicum Pharmaceuticals, Inc share price in Dollar and Rupees. Guide to invest in Bellicum Pharmaceuticals, Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bellicum Pharmaceuticals, Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Bellicum Pharmaceuticals, Inc (BLCM) Key Statistics

in dollars & INR

Previous Close
$0.07475
Open
$0.0801
Market Capitalization
$778.3K
Today's Volume
$6.1K
Revenue TTM
$1.5M
EBITDA
$-23.8M
Earnings Per Share (EPS)
$-0.67
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.93%
Return On Equity TTM
-148.5%

How to invest in Bellicum Pharmaceuticals, Inc Stock (BLCM) from India?

It is very easy for Indian residents to invest directly in Bellicum Pharmaceuticals, Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bellicum Pharmaceuticals, Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bellicum Pharmaceuticals, Inc or BLCM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bellicum Pharmaceuticals, Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bellicum Pharmaceuticals, Inc shares which would translate to null fractional shares of Bellicum Pharmaceuticals, Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Bellicum Pharmaceuticals, Inc, in just a few clicks!

Global Institutional Holdings in Bellicum Pharmaceuticals, Inc

  • Ikarian Capital, LLC

    4.72%

  • Long Focus Capital Management, LLC

    3.45%

  • Baker Bros Advisors LP

    2.62%

  • BlackRock Inc

    0.80%

  • Geode Capital Management, LLC

    0.77%

  • Vanguard Group Inc

    0.70%

Analyst Recommendation on Bellicum Pharmaceuticals, Inc

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Bellicum Pharmaceuticals, Inc(by analysts ranked 0 to 5 stars)

About Bellicum Pharmaceuticals, Inc

Bellicum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen. Its clinical product candidates also include BPX-603, an autologous dual-switch GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing human epidermal growth factor receptor 2 antigen. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is based in Houston, Texas.
Organization
Bellicum Pharmaceuticals, Inc
Employees
13
CEO
Mr. David M. Maggio
Industry
Health Technology

Important FAQs about investing in BLCM Stock from India :

Can Indians buy Bellicum Pharmaceuticals, Inc shares?

Yes, Indians can invest in the Bellicum Pharmaceuticals, Inc (BLCM) from India.

With INDmoney, you can buy Bellicum Pharmaceuticals, Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bellicum Pharmaceuticals, Inc at zero transaction cost.

How can I buy Bellicum Pharmaceuticals, Inc shares from India?

It is very easy to buy Bellicum Pharmaceuticals, Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bellicum Pharmaceuticals, Inc (BLCM) be purchased?

Yes, you can buy fractional shares of Bellicum Pharmaceuticals, Inc with INDmoney app.

What are the documents required to start investing in Bellicum Pharmaceuticals, Inc stocks?

To start investing in Bellicum Pharmaceuticals, Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Bellicum Pharmaceuticals, Inc?

Today's market capitalisation of Bellicum Pharmaceuticals, Inc BLCM is 778.3K

Who is the Chief Executive Officer (CEO) of Bellicum Pharmaceuticals, Inc ?

Mr. David M. Maggio is the current Chief Executive Officer (CEO) of Bellicum Pharmaceuticals, Inc.